At Bonafi, our mission is to keep people safe by helping businesses maximise their ability to maintain the integrity of the pharmaceutical supply chain.

By talking to pharmaceutical manufacturers and wholesalers, we have learned that companies are looking for automation, reliability and a central location to manage the due diligence and maintenance of GxP Customer and Supplier qualifications.

By transforming GxP compliance verifications into Digital Business, we reduce the manual time taken to perform and make processes more robust, traceable and transparent.

SymPhysis Medical

SymPhysis Medical’s goal is to develop innovative technologies that treat a range of chronic diseases and to put the patient experience at the forefront of our solutions’ design to improve their quality of life.

SymPhysis Medical’s emergent technology, RelEase, is a drainage technology to treat a common complication of late-stage cancers, malignant pleural effusion (MPE). MPE causes significant shortness of breath and chest pain in up to 15% of patients with cancer.

The driving force behind SymPhysis Medical is an unwavering commitment to provide independence and improved quality of life for patients with chronic conditions and those requiring palliative care.

Through clinical immersion and using a ‘needs-based’ innovation approach, the team have identified limitations associated with the current treatments for MPE and are collaborating with clinicians, public health nurses, patients and their carers to develop an innovative technology that improves clinical outcomes and betters the patient experience.

A Strategic Clinical Design Tool Built to Reduce Hospital Waiting Lists.